EXACT Sciences Corp. VP Sells $44,461 in Stock (EXAS)
EXACT Sciences Corp. (NASDAQ:EXAS) VP Graham Peter Lidgard sold 3,160 shares of the company’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $14.07, for a total transaction of $44,461.20. Following the completion of the sale, the vice president now directly owns 106,214 shares of the company’s stock, valued at approximately $1,494,431. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of EXACT Sciences Corp. (NASDAQ:EXAS) traded up 0.29% during mid-day trading on Tuesday, hitting $14.00. 1,458,114 shares of the company’s stock traded hands. EXACT Sciences Corp. has a 52-week low of $6.93 and a 52-week high of $14.95. The stock has a 50-day moving average of $13.3 and a 200-day moving average of $12.16. The company’s market cap is $990.6 million.
EXACT Sciences Corp. (NASDAQ:EXAS) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.02. The company had revenue of $1.00 million for the quarter, compared to the consensus estimate of $1.02 million. Analysts expect that EXACT Sciences Corp. will post $-0.72 EPS for the current fiscal year.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.